Delluc S - Search Results

1

Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy.

Gannagé M, Abel M, Michallet AS, Delluc S, Lambert M, Giraudier S, Kratzer R, Niedermann G, Saveanu L, Guilhot F, Camoin L, Varet B, Buzyn A, Caillat-Zucman S. Gannagé M, et al. Among authors: delluc s. J Immunol. 2005 Jun 15;174(12):8210-8. doi: 10.4049/jimmunol.174.12.8210. J Immunol. 2005. PMID: 15944330

2

Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.

Delluc S, Tourneur L, Michallet AS, Boix C, Varet B, Fradelizi D, Guillet JG, Buzyn A. Delluc S, et al. Haematologica. 2005 Aug;90(8):1050-62. Haematologica. 2005. PMID: 16079104

3

DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.

Delluc S, Tourneur L, Fradelizi D, Rubio MT, Marchiol-Fournigault C, Chiocchia G, Buzyn A. Delluc S, et al. Cancer Immunol Immunother. 2007 Jan;56(1):1-12. doi: 10.1007/s00262-006-0170-6. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676183 Free PMC article.

4

Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.

Tourneur L, Delluc S, Lévy V, Valensi F, Radford-Weiss I, Legrand O, Vargaftig J, Boix C, Macintyre EA, Varet B, Chiocchia G, Buzyn A. Tourneur L, et al. Among authors: delluc s. Cancer Res. 2004 Nov 1;64(21):8101-8. doi: 10.1158/0008-5472.CAN-04-2361. Cancer Res. 2004. PMID: 15520222

5

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.

Delluc S, Hachem P, Rusakiewicz S, Gaston A, Marchiol-Fournigault C, Tourneur L, Babchia N, Fradelizi D, Regnault A, Sang KH, Chiocchia G, Buzyn A. Delluc S, et al. Cancer Immunol Immunother. 2009 Oct;58(10):1669-77. doi: 10.1007/s00262-009-0678-7. Epub 2009 Feb 19. Cancer Immunol Immunother. 2009. PMID: 19225777 Free PMC article.

6

Identification and frequency of circulating CD4(+) T lymphocytes specific to Benzylpenicillin in healthy donors.

Nhim C, Delluc S, Halgand F, de Chaisemartin L, Weaver RJ, Claude N, Joseph D, Maillère B, Pallardy M. Nhim C, et al. Among authors: delluc s. Allergy. 2013 Jul;68(7):899-905. doi: 10.1111/all.12173. Epub 2013 Jun 10. Allergy. 2013. PMID: 23751122

7

Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors.

Delluc S, Ravot G, Maillere B. Delluc S, et al. FASEB J. 2011 Jun;25(6):2040-8. doi: 10.1096/fj.10-173872. Epub 2011 Mar 2. FASEB J. 2011. PMID: 21368101

8

Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential.

Delluc S, Ravot G, Maillere B. Delluc S, et al. Blood. 2010 Nov 25;116(22):4542-5. doi: 10.1182/blood-2010-04-280875. Epub 2010 Aug 11. Blood. 2010. PMID: 20702780 Free article.

9

[The prediction of immunogenicity of therapeutic proteins].

Maillère B, Delluc S, Ravot G. Maillère B, et al. Among authors: delluc s. Med Sci (Paris). 2012 Jan;28(1):82-8. doi: 10.1051/medsci/2012281021. Epub 2012 Jan 27. Med Sci (Paris). 2012. PMID: 22289835 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page